Akebia Therapeutics AKBA
NASDAQ AKBA
$0.89 -0.01 (-0.78%)
At close: Sep 29, 2026 · 4:00 PM EDT

Akebia Therapeutics (AKBA) Restructuring Costs (2022 - 2026)

Updated

Akebia Therapeutics (AKBA) recorded Restructuring Costs of $1.95 million in Q2 2026.

Analysis

Akebia Therapeutics (AKBA) Restructuring Costs (2022 - 2026) Analysis & Trends

For FY2024, Akebia Therapeutics reported Restructuring Costs of $58,000, down 68.0% from FY2023.

  • Across earlier years, Restructuring Costs came in at $181,000 in FY2023 (-98.9%) and $15.93 million in FY2022.
  • The Q2 2026 figure is the highest quarterly Restructuring Costs since Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Akebia Therapeutics 241.85 Mn -427.63 Mn 38.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.95 Mn
Mar 31, 2024 58,000.00
Sep 30, 2023 169,000.00
Jun 30, 2023 -94,000.00
Mar 31, 2023 106,000.00
Dec 31, 2022 1.22 Mn
Sep 30, 2022 180,000.00
Jun 30, 2022 14.53 Mn
API Access

Akebia Therapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=AKBA&period=max&api_key=YOUR_API_KEY